d-alpha tocopherol has been researched along with glucagon-like peptide 1 in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bloch, K; Lazard, D; Vardi, P | 1 |
| Dalila, AY; Madani, Z; Malaisse, WJ; Sener, A | 1 |
| Mintziori, G; Polyzos, SA | 1 |
| Newsome, PN; Townsend, SA | 1 |
| Shetty, A; Syn, WK | 1 |
| Brunner, KT; Henneberg, CJ; Long, MT; Wilechansky, RM | 1 |
| Bader, AR; Jeske, R; Westfall, E | 1 |
| Chen, XM; Lv, BD; Ru, QJ; Sun, T; Zhang, B | 1 |
| Chen, Y; Deng, C; Gu, Y; He, Y; Kong, T; Li, J; Shi, J; Sun, L; Yang, L; Zhang, W; Zhou, R | 1 |
6 review(s) available for d-alpha tocopherol and glucagon-like peptide 1
| Article | Year |
|---|---|
Induction of beta-cell resistance to hypoxia and technologies for oxygen delivery to transplanted pancreatic islets.
Topics: Animals; Cell Death; Cell Hypoxia; Cell Separation; Genes, bcl-2; Genetic Engineering; Glucagon-Like Peptide 1; Humans; Insulin-Secreting Cells; Ischemic Preconditioning; Islets of Langerhans Transplantation; Metallothionein; Neovascularization, Physiologic; Oxygen; Pancreas, Artificial; Vascular Endothelial Growth Factor A; Vitamin E; X-Linked Inhibitor of Apoptosis Protein | 2012 |
Emerging and future therapies for nonalcoholic steatohepatitis in adults.
Topics: Adult; Chenodeoxycholic Acid; Drug Design; Glucagon-Like Peptide 1; Humans; Non-alcoholic Fatty Liver Disease; Peroxisome Proliferator-Activated Receptors; Thiazolidinediones; Vitamin E | 2016 |
Review article: new treatments in non-alcoholic fatty liver disease.
Topics: Drug Design; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; MAP Kinase Kinase Kinase 5; Non-alcoholic Fatty Liver Disease; Pioglitazone; Thiazolidinediones; Vitamin E | 2017 |
Current treatment options for nonalcoholic fatty liver disease.
Topics: Antioxidants; Bariatric Surgery; Chalcones; Chenodeoxycholic Acid; Coffee; Diet, Reducing; Dipeptidyl-Peptidase IV Inhibitors; Exercise; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Non-alcoholic Fatty Liver Disease; Peroxisome Proliferator-Activated Receptors; Propionates; Receptors, Cytoplasmic and Nuclear; Sleep; Thiazolidinediones; Ursodeoxycholic Acid; Vitamin E | 2019 |
Nonalcoholic Fatty Liver Disease and Obesity Treatment.
Topics: Bariatric Surgery; Body Weight; Diet; Exercise; Glucagon-Like Peptide 1; Humans; Inflammation; Insulin Resistance; Liver; Liver Cirrhosis; Male; Non-alcoholic Fatty Liver Disease; Obesity; Pioglitazone; Prostatic Neoplasms; Vitamin E; Weight Loss | 2019 |
Comparative efficacy of glucagon-like peptide 1 (GLP-1) receptor agonists, pioglitazone and vitamin E for liver histology among patients with nonalcoholic fatty liver disease: systematic review and pilot network meta-analysis of randomized controlled tria
Topics: Diabetes Mellitus, Type 2; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Necrosis; Network Meta-Analysis; Non-alcoholic Fatty Liver Disease; Pilot Projects; Pioglitazone; Randomized Controlled Trials as Topic; Vitamin E | 2023 |
3 other study(ies) available for d-alpha tocopherol and glucagon-like peptide 1
| Article | Year |
|---|---|
Sardine protein diet increases plasma glucagon-like peptide-1 levels and prevents tissue oxidative stress in rats fed a high-fructose diet.
Topics: alpha-Tocopherol; Animals; Ascorbic Acid; Blood Glucose; Caseins; Catalase; Diet; Energy Intake; Fish Proteins; Fructose; Glucagon-Like Peptide 1; Hydrogen Peroxide; Kidney; Liver; Male; Nitric Oxide; Obesity; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase | 2015 |
Nonalcoholic Fatty Liver Disease: Common Questions and Answers on Diagnosis and Management.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Bariatric Surgery; Biopsy; Diet, Reducing; Elasticity Imaging Techniques; Exercise; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Liver; Liver Cirrhosis; Magnetic Resonance Imaging; Non-alcoholic Fatty Liver Disease; Referral and Consultation; Risk Assessment; Serum Albumin; Severity of Illness Index; Thiazolidinediones; Vitamin E; Vitamins | 2020 |
Tocopheryl quinone improves non-alcoholic steatohepatitis (NASH) associated dysmetabolism of glucose and lipids by upregulating the expression of glucagon-like peptide 1 (GLP-1)
Topics: Animals; Antioxidants; Diet, High-Fat; Disease Models, Animal; Gastrointestinal Microbiome; Glucagon-Like Peptide 1; Glucose; Lipid Metabolism; Male; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Rats; Rats, Sprague-Dawley; Up-Regulation; Vitamin E | 2021 |